Cargando…
An HIV Vaccine Protective Allele in FCGR2C Associates With Increased Odds of Perinatal HIV Acquisition
In the Thai RV144 HIV-1 vaccine trial, a three-variant haplotype within the Fc gamma receptor 2C gene (FCGR2C) reduced the risk of HIV-1 acquisition. A follow-on trial, HVTN702, of a similar vaccine candidate found no efficacy in South Africa, where the predominant population is polymorphic for only...
Autores principales: | Ebonwu, Joy, Lassaunière, Ria, Paximadis, Maria, Goosen, Mark, Strehlau, Renate, Gray, Glenda E., Kuhn, Louise, Tiemessen, Caroline T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668943/ https://www.ncbi.nlm.nih.gov/pubmed/34917081 http://dx.doi.org/10.3389/fimmu.2021.760571 |
Ejemplares similares
-
FCGR3A gene duplication, FcγRIIb-232TT and FcγRIIIb-HNA1a associate with an increased risk of vertical acquisition of HIV-1
por: Ebonwu, Joy, et al.
Publicado: (2022) -
The FCGR2C allele that
modulated the risk of HIV-1 infection in the Thai RV144 vaccine trial is implicated in
HIV-1 disease progression
por: Lassaunière, Ria, et al.
Publicado: (2018) -
Perinatal HIV-1 transmission: Fc gamma receptor variability associates with maternal infectiousness and infant susceptibility
por: Lassaunière, Ria, et al.
Publicado: (2016) -
Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children
por: Kuhn, Louise, et al.
Publicado: (2018) -
Healthy dynamics of CD4 T cells may drive HIV resurgence in perinatally-infected infants on antiretroviral therapy
por: Morris, Sinead E., et al.
Publicado: (2022)